%D9%84%D9%8A%D9%81%D9%8A%D8%AA%D9%8A%D8%B1%D8%A7%D8%B3%D9%8A%D8%AA%D8%A7%D9%85%D9%84%D9%8A%D9%81%D9%8A_%D8%AA%D9%8A%D8%B1%D8%A7_%D8%B3%D9%8A%D8%AA%D8%A7%D9%85LevetiracetamCategory:LevetiracetamLefetiracetamLevetiracetamLevetiracetamLevetiracetam%D9%84%D9%88%D8%AA%DB%8C%D8%B1%D8%A7%D8%B3%D8%AA%D8%A7%D9%85L%C3%A9v%C3%A9tirac%C3%A9tam%D7%9C%D7%91%D7%98%D7%99%D7%A8%D7%90%D7%A6%D7%98%D7%9DLevetiracet%C3%A1mLevetiracetamLevetiracetam%E3%83%AC%E3%83%99%E3%83%81%E3%83%A9%E3%82%BB%E3%82%BF%E3%83%A0%EB%A0%88%EB%B9%84%ED%8B%B0%EB%9D%BC%EC%84%B8%ED%83%90LevetiracetamumLevetiracetamLevetiracetamLewetyracetamLevetiracetamLevetiracetam%D0%9B%D0%B5%D0%B2%D0%B5%D1%82%D0%B8%D1%80%D0%B0%D1%86%D0%B5%D1%82%D0%B0%D0%BCLevetiracetamLevetiracetamLevetiracetam%D0%9B%D0%B5%D0%B2%D0%B5%D1%82%D0%B8%D1%80%D0%B0%D1%86%D0%B5%D1%82%D0%B0%D0%BCLevetiracetamQ417227
about
IV Keppra in the Emergency Department for Prevention of Early Recurrent SeizuresOpen-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With EpilepsyInterdisciplinary Study of Two Novel Anticonvulsants in AlcoholismA 19-week Cognition Study of Levetiracetam in Children With Partial Onset SeizuresClinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: BrivaracetamLevetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial EpilepsySeizure Activity in Alzheimer's DiseaseImaging the Effect of Centrotemporal Spikes and Seizures on Language in ChildrenPharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired PatientsEfficacy of Keppra for Neonatal SeizuresAdd on Lacosamide Versus High Dose MonotherapyLevetiracetam: The Anti-Convulsant of Choice for Elderly Patients With DementiaA Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic SeizuresDosing of Levetiracetam (Keppra) in NeonatesPharmacokinetics of Antiepileptics in Patients on CRRTPhase II Trial of Seizure Prophylaxis in Suspected Primary Glioma Patients Undergoing CraniotomyLevetiracetam for the Treatment of Alcohol Dependence and AnxietyLevetiracetam Treatment of Neonatal SeizuresA Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on PadsevonilAn Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset SeizuresAn Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic SeizuresTreating Hyperexcitability in AD With LevetiracetamHormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to LacosamideLevetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset SeizuresA Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)Pharmacokinetics of Levetiracetam (Keppra) in NeonatesObservational Study in Infants Who Are Prescribed Treatment With Keppra® (Levetiracetam) Oral SolutionStudy of Antiepileptic Drug in Generalised Convulsive Status EpilepticusEffects of Levetiracetam (Keppra) on Alcohol ConsumptionShort Duration Levetiracetam to Extended Course for Seizure Prophylaxis After aSAHSecond or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in ChineseA Randomized, Double-blind, Pharmacokinetics Study to Assess Safety, Tolerability of Levetiracetam 45 Minutes Intravenous Infusion During 4 Days of Bid Dosing in Chinese Healthy VolunteersEnteral Levetiracetam For Seizure Control In Pediatric Cerebral MalariaEffect of Valproate Versus Levetiracetam Monotherapy on Reproductive Functions in Epileptic MalesA Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With EpilepsyEfficacy of Intravenous Levetiracetam in Neonatal SeizuresEstablished Status Epilepticus Treatment TrialTELSTAR: Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation
P4844
Q29006079-0CD81C7C-3A6E-423F-B0DB-00FC499E19D1Q29006124-FA2EC4C8-210E-41F8-8922-6DB626299AAFQ29006125-DABCC7CA-A730-4F1C-AD89-2F71F2975CD1Q29006126-1E767DE7-BE41-4160-9839-DC679B36B9F4Q29006127-14BC4566-F326-4D3A-90F6-6405D58668F5Q29006128-A8A8BF0A-A0E7-48CA-A1B6-D16205817D7EQ29006129-DEB96B52-496C-4C31-96C0-8EC24E827DFAQ29006130-1704910F-FB92-4FD5-B7EF-B53DC0E1A7FFQ29006163-245BF498-1E86-47D2-B042-277C54FBB7AAQ47521534-D62AFA30-1F68-4839-810D-6B3FEE687E66Q47522148-913DEE47-C85F-4D4D-BA9C-24C811763296Q48826012-268645A7-D877-42AB-9F08-EFEE1A48F296
P3781
Q61979166-6CCD5FB9-B7EE-44C9-ADBA-6B1923273641Q61979948-9305D766-026F-4A62-AB78-5339D74F494EQ61981311-45C9AB4D-FB71-4385-B23C-3EB227A97DF0Q62105817-5B8F85FF-282B-4952-9BE4-FD2A60724069Q63063265-8D92B5FF-91F7-4040-9180-9702C326692AQ63318323-5A2709D6-EDBE-4D8E-85F4-F4F4A8271E38Q63318856-75430048-CB7B-4258-B12E-57C2885CC902Q63320173-296DB4ED-2F67-40ED-A035-613833C97313Q63320618-89829797-12A9-44F7-976C-268A7011B2DEQ63320992-1AFCA11C-6C97-4856-8361-A32AD388AD86Q63336496-F1BEE585-B05D-43AB-9D45-3768182144DFQ63337358-965F2F34-1E57-499E-84B9-3D3BA5969565Q63339525-2B6C3A26-BA3B-4199-81D2-5761C1091A2BQ63340407-41C888CB-BA36-4B43-8CF1-02F90BC46575Q63394611-5094DCD4-F07F-4E54-98E1-6FE0F1E69535Q63402257-EF9C7889-39A8-4780-A54A-92D494C40BA6Q63574073-8B00B913-ECB0-48DD-877A-7D5A9B7F930BQ63578786-77E16A3D-1B68-4EB3-80E7-D1BFAEBF8738Q63598865-8F5ABEBD-3BFD-4C6C-A796-B575B2AD2A6AQ63806699-763D231D-D2BE-4841-94C8-80B9C634BE45Q63807496-DED5F469-D6B8-475A-B963-D06C942576D1Q63808578-856CA38B-54EA-44F4-A893-6BA321E17F1EQ63812709-8CBCDC4E-671B-4F5B-B7CD-0788F60D6382Q63816352-6E1D601D-D3AD-4EC7-81CA-3E3C1FE1753AQ63816527-23811BFD-220A-4723-B2D2-7E141FEFA8BEQ63817352-81FB633B-DB55-4528-958B-46A30F1572C0Q63819318-A1B5A47F-6D6A-485B-9B17-96ADE7056A52Q63829775-0B726273-000D-4FA0-B3F9-5D86C9B3485BQ63832261-229BB9DF-B3C5-41C0-B9F0-7037C19C2719Q63833612-F4450571-CD40-41F9-AC12-E67AE6B38E7AQ63837608-93BE6B3E-698D-4D23-9DBC-512C56B8C14DQ63837782-58DD939C-CBEC-4CCC-8123-3B577FBF134CQ63841742-6DC5854D-5108-49BF-B59C-7BF38CFFB5A5Q63841752-DDA1B1AC-457A-4C6C-A191-31B3A4B08766Q64029657-0E690C42-532D-471B-92E8-B58787EF7C40Q64121496-98CC2539-55FF-42F6-85A6-B830266560B6Q64151815-EC5AFBD2-C71E-4B50-9413-77FD9A6950F0Q64172437-1A16B02F-3470-4C41-9164-6C12E827BAB6Q64172806-9B8C83A5-7747-4906-8BEA-B80EBCBAEFECQ64187426-19B02576-5DDA-4EAF-81D5-A82DD1BA530F
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
(S)-etiracetam
@en
Levetiracetam
@ca
Levetiracetam
@de
Levetiracetam
@es
Levetiracetam
@id
Levetiracetam
@it
Levetiracetam
@nb
Levetiracetam
@pt
Levetiracetam
@ro
Levetiracetam
@sh
type
label
(S)-etiracetam
@en
Levetiracetam
@ca
Levetiracetam
@de
Levetiracetam
@es
Levetiracetam
@id
Levetiracetam
@it
Levetiracetam
@nb
Levetiracetam
@pt
Levetiracetam
@ro
Levetiracetam
@sh
altLabel
(-)-(s)-.alpha.-ethyl-2-oxo-1-pyrrolidineacetamide
@en
(S)-Etiracetam
@de
1-pyrrolidineacetamide, .alpha.-ethyl-2-oxo-, (.alpha.s)-
@en
102767-28-2
@fr
C8H14N2O2
@fr
C8H14N2O2
@it
Keppra
@de
Keppra
@it
Keppra
@nb
Keppra
@sv
prefLabel
(S)-etiracetam
@en
Levetiracetam
@ca
Levetiracetam
@de
Levetiracetam
@es
Levetiracetam
@id
Levetiracetam
@it
Levetiracetam
@nb
Levetiracetam
@pt
Levetiracetam
@ro
Levetiracetam
@sh
P2175
P31
P3780
P4964
P6689
P592
P6366
P646
P661
P662
P665
P683
P1748
P2017
CC[C@H](C(=O)N)N1CCCC1=O
P2067
P2115
N0000148644